Ondansetron: 6 Years’ Experience in Paediatric Oncology
1997
The control of nausea and vomiting under cytostatic therapy by a new generation of antiemetics has largely eliminated the importance of one of the significant dose-limiting factors in tumour therapy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI